Approval · Notice of Compliance 26368 · 2021
PMS-DIGOXIN: Notice of Compliance 26368
Issued July 30, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26368
- Date
- July 30, 2021
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Licensing agreement between two companies
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PMS-DIGOXIN | 02518406 | Cancelled Pre Market |
| PMS-DIGOXIN | 02518414 | Cancelled Pre Market |
| PMS-DIGOXIN | 02518422 | Cancelled Pre Market |
| PMS-DIGOXIN | 02518392 | Cancelled Pre Market |